Glyburide Tablet
Product Images NDC 51655-492

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 51655-492). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 492 25 Master Bottle Label Approval Rev A 02 22)

Label for GlyBURIDE tablets USP 5 mg, oral dosage form, containing 60 tablets. The label includes storage instructions to keep at 20°-25°C (68°-77°F) and protect from light, with directions to see the package insert for dosage. Manufactured and repackaged by Northwind Pharmaceuticals, LLC.*

FDA Label Image

Image (Dde70749 E2c1 4ba6 Bdba F08a456e803c 01)

Chemical structure diagram of glyburide, showing its molecular framework including rings, bonds, and functional groups outlined in the illustration.*

FDA Label Image

Logo (Dde70749 E2c1 4ba6 Bdba F08a456e803c 02)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.